Stock Market Today: Dow Jones Roars As Industrials Rescue Wall Street From Meta-Led Tech Slide

A sharp rotation gripped Wall Street at midday Thursday as blue-chip industrials and healthcare powered the Dow higher, masking a savage selloff in mega-cap tech after Meta and Microsoft warned on AI infrastructure spending.

Eli Lilly Raises 2026 Outlook On Strong Mounjaro And Zepbound Demand

Eli Lilly beats Q1 estimates, lifts 2026 outlook as Mounjaro and Zepbound demand offsets pricing pressure and drives strong revenue growth.

Eli Lilly Q1 2026 Earnings Call Transcript

Earnings Scheduled For April 30, 2026

Eli Lilly Q1 Mounjaro Revenue +125% TO $8.70B; Zepbound +79% To $4.10B

Eli Lilly CEO David A. Ricks Said, "A key milestone was the U.S. FDA approval of Foundayo—the only approved GLP-1 pill that can be taken any time of day, without food and water restrictions.

Eli Lilly Raises FY2026 Adj EPS Guidance from $33.50-$35.00 to $35.50-$37.00 vs $34.55 Est; Raises FY2026 Sales Guidance from $80.000B-$83.000B to $82.000B-$85.000B vs $82.100B Est

2026 Financial Guidance In addition to providing guidance for GAAP revenue, Lilly provides guidance for certain non-GAAP measures.The following table summarizes the company's updated full-year 2026 non-GAAP

Eli Lilly Q1 Adj. EPS $8.55 Beats $6.66 Estimate, Sales $19.799B Beat $17.615B Estimate

Eli Lilly (NYSE:LLY) reported quarterly earnings of $8.55 per share which beat the analyst consensus estimate of $6.66 by 28.38 percent. This is a 155.99 percent increase over earnings of $3.34 per share from the same

Elizabeth Warren Calls Trump's '600%' Drug Price Claim Mathematically Impossible: 'His Promise Is As Empty As…'

Sen. Warren challenges Trump's 600% TrumpRx drug price claim using a glass of water.

Eli Lilly Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Eli Lilly & Co. (LLY) will release Q1 earnings on April 30. Analysts expect $6.79/share, up from $3.34/share last year. LLY down 2.6% on Wed.